Crescent Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.30 Cr
as on 24-10-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.90 Cr
as on 24-10-2024
- Revenue -5.20%
(FY 2023)
- Profit -29.57%
(FY 2023)
- Ebitda -23.15%
(FY 2023)
- Net Worth 10.69%
(FY 2023)
- Total Assets 42.04%
(FY 2023)
About Crescent Formulations
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.30 Cr.
The company currently has active open charges totaling ₹21.90 Cr.
Shaik Janimiya, Shaik Thahera, Javeed Shaik, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC070991
- Company No.
070991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2010
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Crescent Formulations?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaik Junaid  | Director | 04-May-2023 | Current |
| Shaik Janimiya | Director | 28-Oct-2010 | Current |
| Shaik Thahera | Director | 28-Oct-2010 | Current |
| Javeed Shaik | Director | 24-Feb-2017 | Current |
Financial Performance of Crescent Formulations.
Crescent Formulations Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.2% decrease. The company also saw a substantial fall in profitability, with a 29.57% decrease in profit. The company's net worth Soared by an impressive increase of 10.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crescent Formulations?
In 2023, Crescent Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Crescent Therapeutics Private LimitedActive 4 years 11 monthsShaik Janimiya, Shaik Thahera and 2 more are mutual person
- Insula Pharmaceuticals Private LimitedActive 7 years 6 months
Shaik Janimiya, Shaik Thahera and 2 more are mutual person
- Gmp Formulations Private LimitedActive 6 years 10 months
Shaik Janimiya, Shaik Thahera and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Mar 2023 | ₹4.00 M | Open |
Others Creation Date: 08 Feb 2023 | ₹4.00 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Feb 2023 | ₹10.09 Cr | Open |
How Many Employees Work at Crescent Formulations?
Crescent Formulations has a workforce of 171 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescent Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
